A plea to stop the speculation from a player who's heard more than his fair share.
Most of our writers didn't enter the world sporting an @baseballprospectus.com address; with a few exceptions, they started out somewhere else. In an effort to up your reading pleasure while tipping our caps to some of the most illuminating work being done elsewhere on the internet, we'll be yielding the stage once a week to the best and brightest baseball writers, researchers, and thinkers from outside of the BP umbrella. If you'd like to nominate a guest contributor (including yourself), please drop us a line.
Gabe Kaplerspent parts of 12 years in the major leagues from 1998-2010, playing for the Tigers (1998-99), Rangers (2000-02), Rockies (2002-03), Red Sox (2003-06 – with a brief interlude in Japan), Brewers (2008) and Rays (2009-10). He also spent a year managing the Red Sox’ Single-A affiliate in Greenville. Follow him on Twitter @gabekapler. You can read his first article for BP here and listen to his recent discussion of advanced stats on Effectively Wild with Ben Lindbergh and Sam Millerhere.
The real danger Biogenesis revealed and the false threat that we shouldn't make this about.
The announcement was mostly anticlimax. Twelve players accepted 50-game suspensions for their involvement with the Biogenesis clinic, and Alex Rodriguez is looking at a longer suspension pending appeal. Some of the names are a surprise, but not the name that everyone is talking about.
The Biogenesis story has, admittedly at the urging of MLB, become primarily about Alex Rodriguez and his massive contract, and Ryan Braun and his improperly handled sample. It is understandable, in that they’re both big stars and the storylines around them are indeed compelling. But there’s a larger story here that’s mostly being missed.
Why Ryan Braun's suspension isn't bad news, and other reflections on the latest in the Biogenesis saga.
Baseball Prospectus has no house style on performance-enhancing drugs, the way we do about, say, punctuation (unspaced em-dash only, please). We haven’t taken an internal poll and decided to condone or condemn PEDs, and we don’t issue an official stance on steroids as part of the author orientation process. But a site devoted to the pursuit of objective knowledge about baseball tends to attract a group of authors who’ve independently developed similar feelings about certain subjects—from batting order to the sacrifice bunt—and so much of our coverage of baseball’s PED problem over the years has held true to a few first principles:
Some 20 players could be suspended for ties to Biogenesis, as the league seeks testimony from Tony Bosch in a case that could have far-reaching financial implications.
Major League Baseball may seek to suspend as many as 20 players, including Alex Rodriguez and Ryan Braun, as part of the investigation into the Miami-area Biogenesis anti-aging clinic, according to a report by ESPN. The league has been pursuing legal avenues, including a lawsuit against Biogenesis, Biokem, Tony Bosch of Biogenesis, and others, seeking damages. That and other pressure may have finally taken a toll on Bosch as, according to the ESPN report, he is ready to cooperate with MLB investigators in exchange for their dropping the case. With Bosch testifying against players, the league could begin the suspension process “within the next few weeks.”
Should all the players be suspended, it would mark the largest number of suspensions for performance-enhancing substances in the history of professional sports. In 2005, the first year of mandatory drug testing, MLB suspended 12 players between April and November of the year, the largest amount of suspensions at the major-league level to date. At the time, first-time suspensions against the joint drug agreement between MLB and the players’ union were only for 10 games. Since then, the number of games a player can be suspended for has increased dramatically to 50 for a first violation, 100 for a second, and a potential permanent suspension from both MLB and minor-league baseball for a third.
Former fringe major leaguer Eric Knott dishes on his difficult decisions about PED use during his time as a professional player.
Most of our writers didn't enter the world sporting an @baseballprospectus.com address; with a few exceptions, they started out somewhere else. In an effort to up your reading pleasure while tipping our caps to some of the most illuminating work being done elsewhere on the internet, we'll be yielding the stage once a week to the best and brightest baseball writers, researchers and thinkers from outside of the BP umbrella. If you'd like to nominate a guest contributor (including yourself), please drop us a line.
Character assassination, speculation, a commitment to process... ah, it has to be Hall of Fame season.
While looking toward the future with our comprehensive slate of current content, we'd also like to recognize our rich past by drawing upon our extensive (and mostly free) online archive of work dating back to 1997. In an effort to highlight the best of what's gone before, we'll be bringing you a weekly blast from BP's past, introducing or re-introducing you to some of the most informative and entertaining authors who have passed through our virtual halls. If you have fond recollections of a BP piece that you'd like to nominate for re-exposure to a wider audience, send us your suggestion.
Before Jeff Bagwell's first year on the Hall of Fame ballot, Christina summed up her attitude toward steroids in the piece reprinted below, which was originally published as a "Prospectus Perspective" column on December 31st, 2010.